Retina

"The story has not yet been fully told."

How one team is on a mission to transform eyecare with simple, clever and low cost engineering.

Timing of vitrectomy for retained lens material is important – but not in the way you might expect.

When performing pars plana vitrectomy to remove retained lens fragments, what’s the rush?

How a subset of retinal ganglion cells might be the answer to jet lag.

Research uncovers hidden sufferings in patients with neovascular AMD.

The first subretinal injection of AAV XLRPGR gene therapy into a patient with retinitis pigmentosa.

How did people react to the news that an unapproved stem cell therapy blinded three patients?

Two approaches that could result in a better retinal implant.

Farhad Hafezi, Professor, The University of Geneva; Chief Medical Officer, The ELZA Institute, Zurich.